Correspondence in response to OSIN-D-18-00831 quantifying imminent risk

J A Kanis^{1

2}, H Johansson^{3

4}, N C Harvey^{5

6}, M Lorentzon^{7

8}, E Liu⁴, F Borgström⁹, E V McCloskey^{3

10}

Affiliations

¹ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@sheffield.ac.uk.
² Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia. w.j.pontefract@sheffield.ac.uk.
³ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
⁴ Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
⁵ MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
⁶ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
⁷ Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
⁸ Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
⁹ LIME/MMC, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Mellanby Centre for Bone Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Comment

J A Kanis et al. Osteoporos Int. 2019 Feb.

. 2019 Feb;30(2):525-526.

doi: 10.1007/s00198-018-4796-y. Epub 2019 Jan 7.

J A Kanis^{1

2}, H Johansson^{3

4}, N C Harvey^{5

6}, M Lorentzon^{7

8}, E Liu⁴, F Borgström⁹, E V McCloskey^{3

10}

¹ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@sheffield.ac.uk.
² Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia. w.j.pontefract@sheffield.ac.uk.
³ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
⁴ Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
⁵ MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
⁶ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
⁷ Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
⁸ Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
⁹ LIME/MMC, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Mellanby Centre for Bone Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

No abstract available

Comment on

Characteristics of recurrent fractures.
Kanis JA, Johansson H, Odén A, Harvey NC, Gudnason V, Sanders KM, Sigurdsson G, Siggeirsdottir K, Fitzpatrick LA, Borgström F, McCloskey EV. Kanis JA, et al. Osteoporos Int. 2018 Aug;29(8):1747-1757. doi: 10.1007/s00198-018-4502-0. Epub 2018 Jun 12. Osteoporos Int. 2018. PMID: 29947869 Free PMC article.
Comments on Kanis et al.: Characteristics of recurrent fractures.
Geusens P, van den Bergh J. Geusens P, et al. Osteoporos Int. 2019 Feb;30(2):529-530. doi: 10.1007/s00198-018-4735-y. Epub 2018 Dec 18. Osteoporos Int. 2019. PMID: 30564863 No abstract available.